Analyst firms · H.C. Wainwright · SAVA
H.C. Wainwright SAVA price target and rating history
Cassava Sciences Inc. (SAVA) · Health Care
H.C. Wainwright rates Cassava Sciences Inc. (SAVA) Neutral with a $116 price target, as of its latest action on Nov 26, 2024. It has published 4 rating actions on SAVA since July 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $116
- Median target, all firms
- Too few
- Actions on SAVA
- 4
H.C. Wainwright price target on SAVA
Every H.C. Wainwright rating on SAVA
- Nov 26, 2024
- Oct 8, 2024
- Jul 1, 2024
- Jul 20, 2021
Questions about H.C. Wainwright and SAVA
- What is H.C. Wainwright's price target for SAVA?
- H.C. Wainwright's latest stated price target for Cassava Sciences Inc. (SAVA) is $116, from its action on Oct 8, 2024.
- What is H.C. Wainwright's rating on SAVA?
- H.C. Wainwright rates SAVA Neutral, a neutral rating, as of Nov 26, 2024.
- When did H.C. Wainwright last change its view on SAVA?
- On Nov 26, 2024, H.C. Wainwright downgrades to Neutral from Buy.
More SAVA rating histories
All H.C. Wainwright ratingsSAVA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.